Heat shock protein 70 family members interact with Crimean-Congo hemorrhagic fever virus and Hazara virus nucleocapsid proteins and perform a functional role in the nairovirus replication cycle

Journal of Virology

Volumn 90, Issue 20, 2016, Pages 9305-9316

  Surtees, Rebecca ^a,b   Dowall, Stuart D ^a,d   Shaw, Amelia ^b   Armstrong, Stuart ^c,d   Hewson, Roger ^a,d   Carroll, Miles W ^a,d   Mankouri, Jamel ^b   A Edwards, Thomas ^b   Hiscox, Julian A ^c,d   Barr, John N ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d NIHR Health Protections Research Unit in Emerging and Zoonotic Infections   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CHAPERONE; HEAT SHOCK PROTEIN 70; NUCLEOCAPSID PROTEIN; RIBONUCLEOPROTEIN; RNA;

ARTICLE; CONTROLLED STUDY; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; EMBRYO; GENETIC VARIABILITY; GENOME ANALYSIS; HAZARA VIRUS; HUMAN; HUMAN CELL; NAIROVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA SYNTHESIS; RNA VIRUS; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; A-549 CELL LINE; CELL LINE; CLIMATE CHANGE; CRIMEAN CONGO HEMORRHAGIC FEVER; EUROPE; GENETICS; HEK293 CELL LINE; METABOLISM; TUMOR CELL LINE; VIROLOGY;

A549 CELLS; CELL LINE; CELL LINE, TUMOR; CLIMATE CHANGE; EUROPE; HEK293 CELLS; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HSP70 HEAT-SHOCK PROTEINS; HUMANS; NAIROVIRUS; NUCLEOCAPSID PROTEINS; RNA; VIRUS REPLICATION;

EID: 84990061872     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00661-16     Document Type: Article

References (51)

1. King AM, Lefkowitz E, Adams MJ, Carstens EB. 2012. Virus taxonomy: classification and nomenclature of viruses: Ninth report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA.
2. Walker PJ, Widen SG, Wood TG, Guzman H, Tesh RB, Vasilakis N. 2016 A global genomic characterization of nairoviruses identifies nine discrete genogroups with distinctive structural characteristics and hostvector associations. Am J Trop Med Hyg 94:1107-1122. http://dx.doi.org/10.4269/ajtmh.15-0917.
3. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M. 2013. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 100: 159-189. http://dx.doi.org/10.1016/j.antiviral.2013.07.006.
4. Hoogstraal H. 1979. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 15:307-417 http://dx.doi.org/10.1093/jmedent/15.4.307.
5. Suleiman MN, Muscat-Baron JM, Harries JR, Satti AG, Platt GS, Bowen ET, Simpson DI. 1980. Congo/Crimean haemorrhagic fever in Dubai. An outbreak at the Rashid Hospital. Lancet ii:939-941.
6. Estrada-Peña A, Ruiz-Fons F, Acevedo P, Gortazar C, de la Fuente J. 2013 Factors driving the circulation and possible expansion of Crimean-Congo haemorrhagic fever virus in the western Palearctic. J Appl Microbiol 114:278-286. http://dx.doi.org/10.1111/jam.12039.
7. Maltezou HC, Papa A. 2010. Crimean-Congo hemorrhagic fever: risk for emergence of new endemic foci in Europe? Travel Med Infect Dis 8:139-143 http://dx.doi.org/10.1016/j.tmaid.2010.04.008.
8. Dowall SD, Findlay-Wilson S, Rayner E, Pearson G, Pickersgill J, Rule A, Merredew N, Smith H, Chamberlain J, Hewson R. 2012. Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus. J Gen Virol 93:560-564. http://dx.doi.org/10.1099/vir.0.038455-0.
9. Treib J, Dobler G, Haass A, von Blohn W, Strittmatter M, Pindur G, Froesner G, Schimrigk K. 1998. Thunderclap headache caused by Erve virus? Neurology 50:509-511. http://dx.doi.org/10.1212/WNL.50.2.509.
10. Montgomery RM. 1917. On a tick-borne gastroenteritis of sheep and goats occurring in Kenya. J Comp Pathol Ther 30:28-57. http://dx.doi.org/10.1016/S0368-1742(17)80002-3.
11. Carter SD, Surtees R, Walter CT, Ariza A, Bergeron E, Nichol ST, Hiscox JA, Edwards TA, Barr JN. 2012. Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J Virol 86:10914-10923. http://dx.doi.org/10.1128/JVI.01555-12.
12. Guo Y, Wang W, Ji W, Deng M, Sun Y, Zhou H, Yang C, Deng F, Wang H, Hu Z, Lou Z, Rao Z. 2012. Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc Natl Acad Sci U S A 109:5046-5051. http://dx.doi.org/10.1073/pnas.1200808109.
13. Wang Y, Dutta S, Karlberg H, Devignot S, Weber F, Hao Q, Tan YJ, Mirazimi A, Kotaka M. 2012. Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: superhelical homo-oligomers and the role of caspase-3 cleavage. J Virol 86:12294-12303. http://dx.doi.org/10.1128/JVI.01627-12.
14. Surtees R, Ariza A, Punch EK, Trinh CH, Dowall SD, Hewson R, Hiscox JA, Barr JN, Edwards TA. 2015. The crystal structure of the Hazara virus nucleocapsid protein. BMC Struct Biol 15:24. http://dx.doi.org/10.1186/s12900-015-0051-3.
15. Wang W, Liu X, Wang X, Dong H, Ma C, Wang J, Liu B, Mao Y, Wang Y, Li T, Yang C, Guo Y. 2015. Structural and functional diversity of nairovirus-encoded nucleoproteins. J Virol 89:11740-11749. http://dx.doi.org/10.1128/JVI.01680-15.
16. Li XD, Makela TP, Guo D, Soliymani R, Koistinen V, Vapalahti O, Vaheri A, Lankinen H. 2002. Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx. J Gen Virol 83:759-766. http://dx.doi.org/10.1099/0022-1317-83-4-759.
17. Taylor SL, Frias-Staheli N, García-Sastre A, Schmaljohn CS. 2009. Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J Virol 83:1271-1279. http://dx.doi.org/10.1128/JVI.00986-08.
18. Mir MA, Duran WA, Hjelle BL, Ye C, Panganiban AT. 2008. Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching. Proc Natl Acad Sci U S A 105:19294-19299. http://dx.doi.org/10.1073/pnas.0807211105.
19. Mir MA, Sheema S, Haseeb A, Haque A. 2010. Hantavirus nucleocapsid protein has distinct m7G cap-and RNA-binding sites. J Biol Chem 285: 11357-11368. http://dx.doi.org/10.1074/jbc.M110.102459.
20. Haque A, Mir MA. 2010. Interaction of hantavirus nucleocapsid protein with ribosomal protein S19. J Virol 84:12450-12453. http://dx.doi.org/10.1128/JVI.01388-10.
21. Mir MA, Panganiban AT. 2008. A protein that replaces the entire cellular eIF4F complex. EMBO J 27:3129-3139. http://dx.doi.org/10.1038/emboj.2008.228.
22. Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, Lundkvist A, Haller O, Mirazimi A. 2004. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 78:4323-4329. http://dx.doi.org/10.1128/JVI.78.8.4323-4329.2004.
23. Andersson I, Simon M, Lundkvist A, Nilsson M, Holmstrom A, Elgh F, Mirazimi A. 2004. Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells. J Med Virol 72:83-93. http://dx.doi.org/10.1002/jmv.10560.
24. Drake JW. 1993. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A 90:4171-4175. http://dx.doi.org/10.1073/pnas.90.9.4171.
25. Leibovitz A, McCombs WM, III, Johnston D, McCoy CE, Stinson JC. 1973 New human cancer cell culture lines. I. SW-13, small-cell carcinoma of the adrenal cortex. J Natl Cancer Inst 51:691-697.
26. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74. http://dx.doi.org/10.1099/0022-1317-36-1-59.
27. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. 1976. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62-70. http://dx.doi.org/10.1002/ijc.2910170110.
28. Cox J, Mann M. 2008. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367-1372. http://dx.doi.org/10.1038/nbt.1511.
29. Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, Gatto L, Fischer B, Pratt B, Egertson J, Hoff K, Kessner D, Tasman N, Shulman N, Frewen B, Baker TA, Brusniak MY, Paulse C, Creasy D, Flashner L, Kani K, Moulding C, Seymour SL, Nuwaysir LM, Lefebvre B, Kuhlmann F, Roark J, Rainer P, Detlev S, Hemenway T, Huhmer A, Langridge J, Connolly B, Chadick T, Holly K, Eckels J, Deutsch EW, Moritz RL, Katz JE, Agus DB, MacCoss M, Tabb DL, Mallick P. 2012. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 30:918-920. http://dx.doi.org/10.1038/nbt.2377.
30. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M. 2005 Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4:1265-1272. http://dx.doi.org/10.1074/mcp.M500061-MCP200.
31. Bergeron E, Albariño CG, Khristova ML, Nichol ST. 2010. Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J Virol 84:216-226. http://dx.doi.org/10.1128/JVI.01859-09.
32. Simon M, Johansson C, Lundkvist A, Mirazimi A. 2009. Microtubuledependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle. Virology 385:313-322. http://dx.doi.org/10.1016/j.virol.2008.11.020.
33. Boulon S, Ahmad Y, Trinkle-Mulcahy L, Verheggen C, Cobley A, Gregor P, Bertrand E, Whitehorn M, Lamond AI. 2010. Establishment of a protein frequency library and its application in the reliable identification of specific protein interaction partners. Mol Cell Proteomics 9:861-879 http://dx.doi.org/10.1074/mcp.M900517-MCP200.
34. Trinkle-Mulcahy L, Boulon S, Lam YW, Urcia R, Boisvert FM, Vandermoere F, Morrice NA, Swift S, Rothbauer U, Leonhardt H, Lamond A. 2008 Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J Cell Biol 183:223-239. http://dx.doi.org/10.1083/jcb.200805092.
35. Saibil H. 2013. Chaperone machines for protein folding, unfolding and disaggregation. Nat Rev Mol Cell Biol 14:630-642. http://dx.doi.org/10.1038/nrm3658.
36. Munday DC, Wu W, Smith N, Fix J, Noton SL, Galloux M, Touzelet O, Armstrong SD, Dawson JM, Aljabr W, Easton AJ, Rameix-Welti MA, de Oliveira AP, Simabuco FM, Ventura AM, Hughes DJ, Barr JN, Fearns R, Digard P, Eleouet JF, Hiscox JA. 2015. Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis. J Virol 89:917-930. http://dx.doi.org/10.1128/JVI.01783-14.
37. Schlecht R, Scholz SR, Dahmen H, Wegener A, Sirrenberg C, Musil D, Bomke J, Eggenweiler HM, Mayer MP, Bukau B. 2013. Functional analysis of Hsp70 inhibitors. PLoS One 8:e78443. http://dx.doi.org/10.1371/journal.pone.0078443.
38. Lahaye X, Vidy A, Fouquet B, Blondel D. 2012. Hsp70 protein positively regulates rabies virus infection. J Virol 86:4743-4751. http://dx.doi.org/10.1128/JVI.06501-11.
39. Couturier M, Buccellato M, Costanzo S, Bourhis JM, Shu Y, Nicaise M, Desmadril M, Flaudrops C, Longhi S, Oglesbee M. 2010. High affinity binding between Hsp70 and the C-terminal domain of the measles virus nucleoprotein requires an Hsp40 co-chaperone. J Mol Recognit 23:301-315 http://dx.doi.org/10.1002/jmr.982.
40. Yu L, Ye L, Zhao R, Liu YF, Yang SJ. 2009. HSP70 induced by Hantavirus infection interacts with viral nucleocapsid protein and its overexpression suppresses virus infection in Vero E6 cells. Am J Transl Res 1:367-380.
41. Li G, Zhang J, Tong X, Liu W, Ye X. 2011. Heat shock protein 70 inhibits the activity of influenza A virus ribonucleoprotein and blocks the replication of virus in vitro and in vivo. PLoS One 6:e16546. http://dx.doi.org/10.1371/journal.pone.0016546.
42. Manzoor R, Kuroda K, Yoshida R, Tsuda Y, Fujikura D, Miyamoto H, Kajihara M, Kida H, Takada A. 2014. Heat shock protein 70 modulates influenza A virus polymerase activity. J Biol Chem 289:7599-7614. http://dx.doi.org/10.1074/jbc.M113.507798.
43. Geller R, Andino R, Frydman J. 2013. Hsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virus. PLoS One 8:e56762. http://dx.doi.org/10.1371/journal.pone.0056762.
44. Noton SL, Nagendra K, Dunn EF, Mawhorter ME, Yu Q, Fearns R. 2015 Respiratory syncytial virus inhibitor AZ-27 differentially inhibits different polymerase activities at the promoter. J Virol 89:7786-7798. http://dx.doi.org/10.1128/JVI.00530-15.
45. Rixon HW, Brown G, Murray JT, Sugrue RJ. 2005. The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen-activated protein kinase p38-dependent tyrosine kinase activity during virus infection. J Gen Virol 86:375-384. http://dx.doi.org/10.1099/vir.0.80563-0.
46. Goloudina AR, Demidov ON, Garrido C. 2012. Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett 325:117-124. http://dx.doi.org/10.1016/j.canlet.2012.06.003.
47. Taguwa S, Maringer K, Li X, Bernal-Rubio D, Rauch JN, Gestwicki JE, Andino R, Fernandez-Sesma A, Frydman J. 2015. Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection. Cell 163:1108-1123. http://dx.doi.org/10.1016/j.cell.2015.10.046.
48. Oglesbee MJ, Liu Z, Kenney H, Brooks CL. 1996. The highly inducible member of the 70 kDa family of heat shock proteins increases canine distemper virus polymerase activity. J Gen Virol 77(Pt 9):2125-2135.
49. Fares MA, Ruiz-Gonzalez MX, Moya A, Elena SF, Barrio E. 2002. Endosymbiotic bacteria: groEL buffers against deleterious mutations. Nature 417:398. http://dx.doi.org/10.1038/417398a.
50. Crowder S, Kirkegaard K. 2005. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses. Nat Genet 37:701-709 http://dx.doi.org/10.1038/ng1583.
51. Geller R, Vignuzzi M, Andino R, Frydman J. 2007. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev 21:195-205. http://dx.doi.org/10.1101/gad.1505307.